4//SEC Filing
Wood Gavin 4
Accession 0001104659-20-136481
CIK 0001621227other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:00 PM ET
Size
5.7 KB
Accession
0001104659-20-136481
Insider Transaction Report
Form 4
Wood Gavin
Chief Financial Officer
Transactions
- Purchase
Ordinary Shares with a nominal value of GBP0.001 per share
2020-12-14$0.69/sh+24,000$16,550→ 57,000 total
Footnotes (4)
- [F1]The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by Gavin Wood. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
- [F2]The 24,000 ordinary shares reported in Column 4 are represented by 4,000 ADSs.
- [F3]The price reported in Column 4 of $0.6896 per ordinary share is derived from the purchase price paid on December 14, 2020 of $4.1375 per ADS divided by six.
- [F4]The 57,000 ordinary shares reported in Column 5 include 33,000 ordinary shares represented by 5,500 ADSs owned by Mr. Wood prior to the purchase reported in Column 4. These shares are held in the form of ADSs by Mr. Wood.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001577539
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:00 PM ET
- Size
- 5.7 KB